Sero-Prevalence and Immunological Profile of SARS-CoV-2 Antibodies in Nigerian Sickle Cell Disease Patients During the COVID-19 Pandemic
Amusan Festus Olatubosun, Ugbomoiko Daniel Ohilebo, Obhioze Augustine Akpoka, Adesina Beatrice Ebun, OniyeAdesolaHelen & Erameh Theophilus Ogie · Advances in Research · 2025
Introduction: Nigeria has the highest prevalence of sickle cell disease (SCD) globally, making it a major genetic disorder of public health concern in Africa. During the COVID-19 pandemic, SCD patients were particularly vulnerable due to their compromised immune and hematological...
Open access
Research Article
10.9734/air/2025/v26i31352